Navigation Links
New Government Data: Mail-Service Pharmacies Grow, But Public Programs Lag Behind
Date:2/25/2008

WASHINGTON, Feb. 25 /PRNewswire-USNewswire/ --- New, independent government data from the Agency for Healthcare Research & Quality (AHRQ) suggests that while mail-service pharmacies serve a disproportionate share of seniors and individuals with chronic conditions, public programs are not taking full advantage of this increasingly popular and proven cost-saving pharmacy option, the Pharmaceutical Care Management Association (PCMA) said today. At a time when policymakers are seeking public program savings, PCMA believes strongly that the mail-service pharmacy option could be an important tool to achieving greater savings without sacrificing access to needed medications.

"The more consumers know about the savings and convenience of the mail-service pharmacy option, the more they like it. Since public programs lag behind in this area, they should explore new ways to promote this important option," said PCMA President and CEO Mark Merritt.

The new mail-service pharmacy data is contained in a new report from the Agency for Healthcare Research & Quality (AHRQ), entitled Comparing Population Characteristics of Persons Purchasing Prescribed Drugs from Mail Order Pharmacies with Persons Purchasing Prescribed Drugs from Other Outlets, 2005. Among the key findings suggested by the new data:

-- The proportion of individuals relying on a mail-service pharmacy jumped by 50 percent from 2000 to 2005, from 8.8 to 13.2 percent. All other drug-delivery models declined during this time period;

-- Seniors are far more likely to use mail-order pharmacies than the under 65 population;

-- Individuals with at least one chronic condition are far more likely to use mail-service pharmacies than other pharmacy options; and

-- Those individuals relying only on public programs for health coverage lag far behind using mail order, compared to drugstores and other options like clinics and hospitals, suggesting that there is an opportunity for public programs to increase reliance on mail-order pharmacies.

According to a September 2006 report commissioned by PCMA and conducted by the Lewin Group, mail-service pharmacies are projected to reduce costs to consumers and payors by $85 billion in Medicare and the commercial marketplace during the time period 2007 to 2016. If mail-service pharmacies were used to their full potential in Medicare and the commercial marketplace, the ten-year cost savings could double - to $167 billion.

PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D.

Agency for Healthcare Research & Quality (AHRQ) Report:

http://www.meps.ahrq.gov/mepsweb/data_files/publications/st200/stat200. pdf


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. United BioSource Scientist Leads Development of New Guidelines for Drug Reimbursement by German Government
2. Pain Relief Network Sues to Halt Government Actions Taken Against Kansas Patients
3. TeamStaff Hires Jeff Davis as Director of Operations for Government Solutions Subsidiary
4. TeamStaff Renames Subsidiary to Reflect Expanding Government Services
5. Isis Announces Approximately $2.8 Million in Government Grants and Contracts Awarded to its Ibis Subsidiary to Advance Ibis Pathogen Identification Technology
6. Psoriasis Cure Now Applauds Record Government Psoriasis Research Funding
7. OIG and HCCA Issue Government-Industry Roundtable Report
8. Changes needed in how federal government evaluates efficiency of research at EPA, other agencies
9. Rx for Africa, Inc. to Benefit from New Ethiopian Government Policy on Pharma Industry
10. Government dietary guidelines, unintended consequences and public policy
11. Federal Government Receives Failing Grades on Tobacco Control in Annual American Lung Association Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: